-
Drexel researchers develop rapid cantilever biosensor
Technology has applications from E. coli and anthrax to prostate cancer
-
-
Argonne researchers corral E. coli
Unlike traditional centrifuging techniques, the new approach allows selective concentration of healthy cells
-
-
Intralytix seeks FDA approval of E. coli spray
Intended to control pathogens in food processing and medical setting, technique relies on microphages to immobilize bacteria
-
-
MedImmune accepts $15.6 billion buy-out offer
AstraZeneca outbids Merck and others to get its hands on the FluMist vaccine
-
-
TB victim receives TV
Facing a life of civil commitment, Russian-born Arizonan earns his creature comforts
-
-
General Dynamics Canada wins Canadian bio-sensor contract
After six years of succesful naval deployments, government will buy CAN$30 million worth of GDC’s VP Bio Sentry systems
-
-
Biotech industry set to break flu vaccine production record
Officials say industry will produce 132 million doses, with both Sanofi and MedImmune ramping up production capacity
-
-
FDA approves first bird flu vaccine
Government has been stockpiling Sanofi Pasteur’s vaccine for some time, but now it can be distributed without signed consent; concerns remain about efficacy
-
-
Digital angel buys Chemring's McMurdo
$7.5 million deal expected to pay dividends in 2009 when COSPAS-SARSAT equipment is replaced
-
-
NIH awards $23 million for six new influzena research centers
Federal government gets serious by expanding the Centers of Excellence for Influenza Research and Surveillance program
-
-
VaxGen tries to regroup
After HHS cancels its $877 million anthrax vaccine, company looks to merge or partner with others
-
-
Protein Sciences tests caterpillar-based flu vaccine
New approach to vaccine development relies on insect cells rather than bird eggs; method offers improved speed and safety
-
-
MedImmune to explore buy-out options
Board of directors reacts to heightened interest from Big Pharma and growing shareholder disatisfication
-
-
New technology turns A and B blood to O
A fresh approach to an old concept, ZymeQuest tests a machine capable of treating eight units in ninety minutes
-
-
DoE tests Isonics's aerosol bio-decontamination system
Company receives $1 million in funding to perfect technology; tests come as Isonics faces delisting from Nasdaq
-
The long view
WHO Updates List of Most Dangerous Viruses and Bacteria
The WHO recently published a report outlining the findings of its global pathogen prioritization process that involved more than 200 scientists who evaluated evidence related to 28 viral families and one core group of bacteria, covering 1,652 pathogens.
U.S. Capable of Achieving Seafood Independence, New Study Shows
From lobster to haddock and seaweed, seafood plays an important role in the U.S. economy, diet and culture. The nation is one of the top producers of marine and aquatic foods worldwide, but also the second largest seafood importer.